M28 Capital Management LP
An institutional investment manager in STAMFORD, CT. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1807489.
- Reported value$47.2m
- Positions9
Holdings: 9 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd | SHS | Y95308105 | 26.7 | 56.5% | 4,588,284 | Unchanged | |
| Invivyd IncIVVD | COM | 00534A102 | 8.1 | 17.1% | 9,248,250 | Unchanged | |
| TG Therapeutics IncTGTX | COM | 88322Q108 | 4.9 | 10.3% | 88,354 | Unchanged | |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 3.0 | 6.4% | 36,851 | Unchanged | |
| Fractyl Health Inc | COM | 35168W103 | 1.5 | 3.1% | 1,856,117 | Unchanged | |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | 1.1 | 2.4% | 599,793 | Unchanged | |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 1.1 | 2.4% | 101,203 | Unchanged | |
| Rocket Pharmaceuticals IncRCKT | COM | 77313F106 | 0.7 | 1.5% | 210,871 | Unchanged | |
| Curis Inc | COM | 231269309 | 0.1 | 0.3% | 284,889 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0000902664-26-003441 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.